NASDAQ:SELB
Selecta Biosciences, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
selectabio.comipo date
Jun 22, 2016
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. It is also developing biologic the...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus